Coronary virus 229E capsid from MYBIOSOURCE INC.
Search, find, compare suppliers for Coronary virus 229E capsid products.
| Edit | |
|---|---|
| Product Name | Coronary virus 229E capsid |
| Description | Purified by a proprietary chromatographic technique with 95% purity on 12% SDS-PAGE. Coronavirus 229E was found in the early 1960s responsible for 10-30% all common cold. In coronary virus family, coronavirus 229E is classified as group 1, while SARS-CoV outbreak on 2002 in China classified as group 2. Coronavirus 229E nucleocapsid has strong immunogenicity, reactive to its specific antibody produced by infected individuals. Recombinant 229E nucleocapsid has been used as a diagnostic agent to detect anti-coronavirus antibody in clinical study. Recombinant coronavirus 229E nucleocapsid is expressed and purified from E Coli, it contains 360 amino acids derived from its nucleocapsid sequence, a C-terminal 6 x His tag is linked to this recombin. MW: 38KDa |
| Size | 1 mg, 2 mg, 5 mg |
| Concentration | n/a |
| Applications | Immunoassay (IA) |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | MBS596022 |
| Price | $315, $545, $1220 |
| Order / More Info | Coronary virus 229E capsid from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Products